BioCentury | Sep 28, 2015
Clinical News

GynTect regulatory update

...used when patients are diagnosed with an abnormal Pap smear or a high-risk HPV infection. oncgnostics...
...coming months” in Germany and other European markets. GynTect uses epigenetic technology licensed from MDxHealth. oncgnostics GmbH...
Items per page:
1 - 1 of 1
BioCentury | Sep 28, 2015
Clinical News

GynTect regulatory update

...used when patients are diagnosed with an abnormal Pap smear or a high-risk HPV infection. oncgnostics...
...coming months” in Germany and other European markets. GynTect uses epigenetic technology licensed from MDxHealth. oncgnostics GmbH...
Items per page:
1 - 1 of 1